TRCT
PHGE icon

Tower Research Capital (TRC)’s BiomX PHGE Stock Holding History

Tower Research Capital (TRC)’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$4K – 6457
2021
Q3 		$4K Buy
8
+2
+33% +$1.55K ﹤0.01% 4991
2021
Q2 		$6K Buy
+6
New +$6.98K ﹤0.01% 4638
2020
Q3 		– Sell
-2
Closed -$2K – 5034
2020
Q2 		$2K Buy
+2
New +$2.22K ﹤0.01% 4528

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s PHGE Position: Q4 2021 in Review

Tower Research Capital (TRC) sold out of BiomX (PHGE) in Q4 2021, closing a stake of 8 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in PHGE in Q2 2020 and held it in 3 quarters. The position peaked at $6K in Q2 2021. 13 funds tracked by Wall St. Rank hold PHGE as of Q4 2021.

  • Tower Research Capital (TRC) reported no remaining BiomX position as of Q4 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8 BiomX shares in Q4 2021, an estimated $4K.
  • Tower Research Capital (TRC) first reported a position in BiomX in Q2 2020 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s BiomX position peaked at $6K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held BiomX as of Q4 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.